We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
+24.89%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
AUM
$21.5B
AUM Growth
+$4.34B
Cap. Flow
+$423M
Cap. Flow %
1.97%
Top 10 Hldgs %
19.17%
Holding
2,170
New
686
Increased
353
Reduced
351
Closed
575

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.42%
2 Technology 5.01%
3 Healthcare 1.9%
4 Consumer Discretionary 1.75%
5 Financials 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSX icon
1151
CSX Corp
CSX
$90.1B
$951K ﹤0.01%
20,000
-115,000
-85% -$5.19M
FPS
1152
Forgent Power Solutions
FPS
$8.15B
$950K ﹤0.01%
+17,000
New +$776K
ICLN icon
1153
PUT
iShares Global Clean Energy ETF
ICLN
$2.08B
$947K ﹤0.01%
+46,200
New +$958K
NVAX icon
1154
PUT
Novavax
NVAX
$1.52B
$942K ﹤0.01%
100,000
-350,000
-78% -$3.14M
NIOBW
1155
NioCorp Developments Ltd Warrant
NIOBW
$54.7M
$936K ﹤0.01%
668,553
FDMT icon
1156
CALL
4D Molecular Therapeutics
FDMT
$753M
$931K ﹤0.01%
+70,000
New +$682K
ARGX icon
1157
argenx
ARGX
$61.3B
$928K ﹤0.01%
+1,000
New +$825K
RKT icon
1158
PUT
Rocket Companies
RKT
$37.3B
$906K ﹤0.01%
57,500
-133,000
-70% -$1.92M
ABR icon
1159
CALL
Arbor Realty Trust
ABR
$843M
$905K ﹤0.01%
166,900
+33,500
+25% +$218K
KPTI icon
1160
PUT
Karyopharm Therapeutics
KPTI
$34.9M
$904K ﹤0.01%
92,500
-2,500
-3% -$21.7K
NKE icon
1161
CALL
Nike
NKE
$53.7B
$903K ﹤0.01%
22,000
-3,000
-12% -$132K
FCEL icon
1162
CALL
FuelCell Energy
FCEL
$1.22B
$900K ﹤0.01%
+25,000
New +$406K
SRPT icon
1163
PUT
Sarepta Therapeutics
SRPT
$2.19B
$899K ﹤0.01%
50,000
CE icon
1164
CALL
Celanese
CE
$5.18B
$897K ﹤0.01%
19,500
+7,000
+56% +$405K
HRTX icon
1165
PUT
Heron Therapeutics
HRTX
$59.6M
$896K ﹤0.01%
2,100,000
TE
1166
PUT
T1 Energy
TE
$1.27B
$891K ﹤0.01%
94,000
-50,000
-35% -$355K
CAI
1167
PUT
Caris Life Sciences
CAI
$8.05B
$891K ﹤0.01%
50,000
-50,000
-50% -$895K
BCAX
1168
CALL
Bicara Therapeutics
BCAX
$1.5B
$891K ﹤0.01%
+30,000
New +$670K
BCAX
1169
PUT
Bicara Therapeutics
BCAX
$1.5B
$891K ﹤0.01%
30,000
-14,600
-33% -$326K
DV icon
1170
DoubleVerify
DV
$2.09B
$890K ﹤0.01%
82,059
OPTU
1171
Optimum Communications Inc
OPTU
$377M
$886K ﹤0.01%
+611,170
New +$760K
UPST icon
1172
Upstart Holdings
UPST
$2.46B
$886K ﹤0.01%
25,000
-5,000
-17% -$154K
ANVS icon
1173
CALL
Annovis Bio
ANVS
$47.7M
$883K ﹤0.01%
+474,900
New +$924K
NTR icon
1174
CALL
Nutrien
NTR
$37.6B
$881K ﹤0.01%
14,000
-15,100
-52% -$1.06M
KMB icon
1175
Kimberly-Clark
KMB
$32.8B
$878K ﹤0.01%
8,000
+2,000
+33% +$198K

Similar funds

Caption Management's Q2 2026 Portfolio in Review

As of Q2 2026, Caption Management held 2,170 positions worth $21.5B, up 25% from $17.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Caption Management's Q2 2026 filing shows 686 new, 353 increased, 351 reduced and 575 closed positions. Its largest new stake was TSMC: 565,700 shares worth $270M. The largest sale was Meta Platforms (Facebook), an estimated $52.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 88% of assets, down from 89% a quarter earlier, followed by Technology and Healthcare.

  • Caption Management's largest Q2 2026 buy was TSMC: 565,700 shares worth $270M.
  • Caption Management added most to Microsoft in Q2 2026, an estimated $198M increase.
  • Caption Management's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $52.2M.
  • Caption Management fully exited Planet Labs PBC Warrants in Q2 2026, selling an estimated $24.9M.
  • Caption Management's ten largest holdings make up 19% of its $21.5B portfolio in Q2 2026.
  • Caption Management opened 686 new positions and closed 575 in Q2 2026.
  • Caption Management's portfolio value rose 25% quarter-over-quarter to $21.5B.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.